- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05.03. | IQ-AI Limited - Grant of Options | - | RNS | ||
| 01.03. | IQ-AI Limited - Holding(s) in Company | 1 | RNS | ||
| 26.02. | IQ-AI Limited - Result of Broker Option and Total Voting Rights | - | RNS | ||
| 22.02. | IN BRIEF: IQ-AI shares sink on discounted placing fundraise | 1 | Alliance News | ||
| 22.02. | IQ-AI Limited - Placing and Broker Option | - | RNS | ||
| 09.02. | IQ-AI subsidiary asked by FDA to resubmit and modify application | 1 | Alliance News | ||
| 09.02. | IQ-AI Limited - FDA Application Update | - | RNS | ||
| 02.02. | IN BRIEF: IQ-AI celebrates USD100,000 grant for subsidiary | 1 | Alliance News | ||
| 02.02. | IQ-AI Limited - IB awarded a $100,000 grant | - | RNS | ||
| 22.01. | IQ-AI Limited - Holding(s) in Company | - | RNS | ||
| 15.01. | IQ-AI Limited - Director Dealings and Conversion of CLNs | - | RNS | ||
| 15.01. | IQ-AI Limited - Holding(s) in Company | - | RNS | ||
| 10.01. | IQ-AI falls after subsidiary notes launch of treatment access scheme | 1 | Alliance News | ||
| 10.01. | IQ-AI Limited - IB Launching an Expanded Access Program for GaM | - | RNS | ||
| 19.12.23 | IQ-AI firm gets US FDA fast-track status for oral gallium maltolate | 1 | Alliance News | ||
| 19.12.23 | IQ-AI Limited - Imaging Biometrics granted FDA "Fast-Track" | - | RNS | ||
| 05.12.23 | IQ-AI stock rises on positive interim results from glioblastoma trial | 2 | Alliance News | ||
| 05.12.23 | IQ-AI Limited - IQ-AI Announces Positive Interim Phase 1 Results | - | RNS | ||
| 20.11.23 | IQ-AI Limited - Holding(s) in Company | - | RNS | ||
| 09.11.23 | IQ-AI Limited - Director Dealing and Conversion of CLNs | - | RNS |
Seite:
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GERRESHEIMER | 99,90 | +0,71 % | JEFFERIES stuft GERRESHEIMER AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Gerresheimer von 126 auf 128 Euro angehoben und die Einstufung auf "Buy" belassen. Es werde wohl noch ein Quartal dauern... ► Artikel lesen | |
| MCKESSON | 503,40 | +0,04 % | McKesson declares $0.62 dividend | ||
| LIMES SCHLOSSKLINIKEN | 350,00 | 0,00 % | Limes Schlosskliniken erwartet Zuwachs bei Umsatz und EBITDA | Die Kölner Limes Schlosskliniken AG meldet für 2023 einen Anstieg der Gesamterträge um 26 Prozent auf 37,4 Millionen Euro. Vor Zinsen und Steuern sinkt der Gewinn um 22 Prozent auf 4,7 Millionen Euro... ► Artikel lesen | |
| BEYOND AIR | 1,120 | +1,82 % | Beyond Air Reports Financial Results for Third Quarter of Fiscal Year 2024 | Commercial demand for LungFit® PH increasing; manufacturing of upgraded devices is ramping up to meet growing demand PMA supplement for the expansion of LungFit PH label to include cardiac surgery... ► Artikel lesen | |
| CLEARDAY | 0,550 | 0,00 % | Clearday, Inc.: Clearday introduces digital assistants in residential communities | ||
| HEALTHCARE SERVICES GROUP | 10,100 | -0,98 % | HCSG Reports Q1 2024 Results | BENSALEM, PA--(BUSINESS WIRE)--Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended March 31, 2024.
Ted Wahl, Chief Executive Officer, stated, "Our... ► Artikel lesen | |
| INTERPACE BIOSCIENCES | 1,270 | -1,55 % | Interpace Biosciences, Inc.: Interpace Biosciences Announces Record Third Quarter 2023 Financial and Business Results | - Q3 Revenue of $9.1 million; an 11% increase year-over-year - Q3 Test volume up 11% year-over-year - Q3 Reimbursement improvement up 11% year-over-year, driven by additional commercial contracts... ► Artikel lesen | |
| VYANT BIO | 0,232 | 0,00 % | Vyant Bio, Inc.: Vyant Bio Provides Update on Winddown Activities | CHERRY HILL, N.J., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. ("Vyant Bio" or "Company") (OTC: VYNT) is providing an update to shareholders regarding its winddown activities pursuant to its... ► Artikel lesen | |
| ADDUS HOMECARE | 84,50 | 0,00 % | Addus HomeCare Corp - 8-K, Current Report | ||
| MODERN DENTAL | 0,590 | 0,00 % | MODERN DENTAL (03600): NOTIFICATION LETTER TO NON-REGISTERED HOLDER - NOTICE OF PUBLICATION OF ANNUAL REPORT 2023, CIRCULAR, NOTICE OF ANNUAL GENERAL ... | ||
| ICU MEDICAL | 90,50 | +2,26 % | ICU Medical's Smiths Medical is reportedly closing a New Hampshire plant, cutting 220 jobs | ||
| XYLO TECHNOLOGIES | 1,570 | 0,00 % | XYLO TECHNOLOGIES LTD - 6-K, Report of foreign issuer | ||
| ACADIA HEALTHCARE | 68,50 | 0,00 % | Acadia Healthcare upgraded at Deutsche Bank on risk-reward profile | ||
| FRESH2 GROUP | 0,570 | +39,71 % | Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq | New York, NY, April 22, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ: FRES) ("Fresh2" or the "Company"), a B2B e-commerce and supply chain management company within the restaurant and food... ► Artikel lesen | |
| THERACLION | 0,345 | 0,00 % | Theraclion Announces 2023 Financial Results and Continues Its Roadmap | Continuation of the strategy focused on access to the US and Chinese markets for SONOVEIN®, and its improvement through R&D;
Rapid start-up of the pivotal study in the United States: two-thirds... ► Artikel lesen |
Das Unternehmen IQ-AI LIMITED kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,010 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
